Autopsy report · NCT01597440

Long-term Outcome of N-Carbamylglutamate Treatment in Propionic Acidemia and Methylmalonic Acidemia

“insufficient enrollment”

The sponsor’s own words in the registry.

Life of this trial

• Registered 4 months before it started.
• Ran for about 2 years 5 months before it stopped.
• 1 participant enrolled.
• Results were posted on the registry 2 years 2 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Mendel Tuchman

Sponsor type

University, hospital or other

Conditions

Propionic Acidemia; Methylmalonic Acidemia

Interventions

N-carbamylglutamate; Standard of Care

Participants

1

Sites

7

Countries

United States

Trials that died the same way

• Cellular Immunotherapy Treatment Antigen-Directed for EBV Lymphoma
  “Insufficient enrollment rate” (91% match in meaning)
• Treatment Prior to Injection and Biopsy of the Vulva
  “Not enough enrollment” (91% match in meaning)
• Family Nurture Intervention in the CHoNJ NICU
  “insufficient enrollment numbers” (91% match in meaning)
• Development of Auditory Skills in Young Deaf Children With Bilateral Cochlear Implants
  “Not sufficient enrollment” (89% match in meaning)
• Collective Accuryn Physiologic Signals and Signatures
  “Lack of Enrollment” (89% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.